Zentalis
The Associate Director, Medical Writing provides strategic expertise in creating complex clinical and regulatory documents for health authority submissions within an oncology innovator. The role involves leading standardized document development processes, managing external writers, and collaborating with cross-functional teams to ensure high-quality submissions for investigational drugs.
Zentalis Pharmaceuticals is a clinical-stage oncology company focused on developing azenosertib, a first-in-class oral WEE1 kinase inhibitor, for Cyclin E1-positive platinum-resistant ovarian cancer and other tumor types. The company is advancing azenosertib through late-stage, registration-intended clinical trials, including the Phase 3 ASPENOVA trial, using a biomarker-directed approach to provide a non-chemotherapy targeted therapy option. Zentalis engages the investor and medical communities through detailed pipeline, financial, and governance resources from its headquarters in San Diego, CA.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Zentalis.
Zentalis didn’t post a salary, so this is our estimate from similar listings.
Right around the average for this role